Loading viewer...
investor_presentation
Format: PDF investor_presentation
wide-16x9W -v2 © 2019 Lam Research Corp. | 01.23.2019 1 Lam Research Corporation December Quarter 2018 Financial Results January 23, 2019
© 2019 Lam Research Corp. | 01.23.2019 1
Lam Research Corporation
December Quarter 2018 Financial Results
January 23, 2019wide-16x9W -v2
© 2019 Lam Research Corp. | 01.23.2019 2Cautionary Statement Regarding Forward -Looking Statements
This presentation and the accompanying discussion contain “forward -looking statements” under U.S. securities laws. Forward -looking
statements include any statements that are not statements of historical fact. Examples of forward -looking statements include, b ut are not
limited to: (1) anticipated business, balance sheet, cash flow and financial measures and results, including guidance, whethe r on a GAAP or
non-GAAP basis; (2) economic, market, industry and industry segment expectations; and (3) our ability to successfully execute bu siness, capital
allocation, product and growth plans or strategies, or otherwise deliver value for customers and stockholders. Forward -looking statements
speak only as of the date they are made and are subject to risks and uncertainties that could cause actual results to differ materially from
those expressed, including the factors discussed in our filings with the Securities and Exchange Commission (“SEC”). You sho uldnot place undue
reliance on forward -looking statements. Lam undertakes no obligation to update any forward -looking statements. wide-16x9W -v2
© 2019 Lam Research Corp. | 01.23.2019 3Business Review and Industry Outlook
President and Chief Executive Officerwide-16x9W -v2
© 2019 Lam Research Corp. | 01.23.2019 42018 Calendar Year Financial Performance
$10,871M in Revenue –14% increase
Operating Cash Flow growth over
50% from 2017EPS growth of 27% from 2017*
*Data calculated on a non -GAAP basis. Reconciliations of U.S. GAAP results to non -GAAP results can be found at the end of this presentation2018 Strongest
© 2019 Lam Research Corp. | 01.23.2019 5Industry Overview
Lam is well -positioned to deliver attractive long -term growth and opportunityCalendar 2018 WFE ended largely as expected at ~ $50B
Expect WFE down from 2018 in the mid to high teens range
Memory -led decline in industry spending entering 2019
© 2019 Lam Research Corp. | 01.23.2019 6Lam’s Growth Strategy
Increasing the Recurring
Gaining Market Share
Served Available Markets
© 2019 Lam Research Corp. | 01.23.2019 7Etch and Deposition -Central to Customers’ Technology Roadmaps
A strong pipeline of differentiated products, targeting our customers’ most difficult
Preview truncated — download the full document for the complete content.
investor_presentation
23 Pages
investor_presentation
63 Pages
Puma Biotechnology
Regeneron Pharmaceuticals Corporate Presentation 2023
investor_presentationinvestor_presentation
31 Pages
Regeneron Pharmaceuticals, Inc.
investor_presentation
AIM ImmunoTech
CapitaLand Investment Limited 2024 Fixed Income Roadshow
investor_presentationinvestor_presentation
61 Pages
CapitaLand Investment Limited